Latest News and Press Releases

DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for...

Newly Appointed Board Chair, Philip Astley-Sparke, Brings Transatlantic Late-Stage Development, Regulatory and Commercial Expertise Strengthened Leadership and Expanded U.S. Presence Positions SynOx...

Dublin, March 21, 2025 (GLOBE NEWSWIRE) -- The "Microbiome Disease - Pipeline Insight, 2025" drug pipeline report has been added to ResearchAndMarkets.com's offering.The report provides...

Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies, RNAi-Based...

Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Ebola Fever - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.This report captures an exhaustive analysis of the...

Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Market by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033" report has been added to ...

Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Cancer Monoclonal...

Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Biologics Fill Finish Services Market: Industry Trends and Global Forecasts to 2035" report has been added to ResearchAndMarkets.com's offering. The...

Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Biologics was estimated...

Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market Size, Share & Trends Analysis by Drug Type, Indication, and Region, 2025-2030" report has been added to ...